Sort   by:  
 Page size 
UnknownPhase II study of the safety and antitumor activity of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma.
Not available
S-EPMC4588714 | biostudies-literature
UnknownA d-Amino Acid at the N-Terminus of a Protein Abrogates Its Degradation by the N-End Rule Pathway.
Not available
S-EPMC4711398 | biostudies-literature
UnknownSynthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity.
Not available
S-EPMC8448747 | biostudies-literature
UnknownDynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction.
Not available
S-EPMC7380118 | biostudies-literature
UnknownTranscriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic Leukemia.
Not available
S-EPMC5127278 | biostudies-literature
UnknownTwo phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Not available
S-EPMC4159618 | biostudies-literature
Sort   by:  
 Page size